Abstract
Background
Despite lower incidence rates among black women and a national decline in breast cancer (BC) deaths, there is a widening gap in BC mortality rates between black and white women in the United States. A previous study evaluating data from 1992 to 1999 found a racial disparity in the receipt of surveillance mammography. We sought to evaluate whether this disparity persists between black and white women diagnosed with BC between 2000 and 2011.
Methods
Using the SEER-Medicare registry, we conducted an analysis of women ≥ 66 years diagnosed with early-stage (0–III) BC between 2000 and 2011 who underwent BC surgery. The primary outcome was receipt of surveillance mammography within 12 months of surgery. Chi square analyses were used to compare characteristics between black and white women. Multivariate logistic regression was used to assess receipt of surveillance mammography after controlling for potential confounders.
Results
There were 3353 black and 40,564 white women in the final cohort. After adjusting for confounders, black women were still 24% less likely than white women to receive surveillance mammography (Odds ratio 0.76, 95% CI 0.70–0.0.82). Those who were married, younger, in the highest income quartile, diagnosed at earlier stages, had a lower comorbidity score, or who resided in metropolitan areas were more likely to receive surveillance mammography (p < 0.05).
Conclusion(s)
We found that older black BC survivors continue to experience lower rates of surveillance mammography, even after adjusting for multiple potential confounders. There remains a need to investigate which individual and systemic factors affect disparities in breast cancer care.
Similar content being viewed by others
Data availability
This analysis used data from the Surveillance, Epidemiology and End Results registry linked to Medicare claims (SEER-Medicare). Given concern for patient and provider confidentiality, this dataset is not publicly available, but may be obtained by request and with permission from NCI SEER-Medicare.
Change history
05 June 2019
In the original publication of the article, under the Methods section, second paragraph, the sentence that reads as “We excluded 3047 patients … surgical treatment (see Fig. 1)” should read as “We excluded 3047 patients who did not identify as black or white, 5395 who were not initially diagnosed with stage 0–III cancer or were missing stage or residence data, 2573 patients who passed away within 18 months of diagnosis, and 4716 patients who did not undergo primary surgical treatment (see Fig. 1)”.
References
DeSantis CE, Fedewa SA, Goding Sauer A et al (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin 66(1):31–42
Siegel RL, Miller KD, Jemal A (2018) Cancer Statistics, 2018. CA Cancer J Clin 68(1):7–30
Miller KD, Siegel RL, Lin CC et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289
DeSantis C, Siegel R, Bandi P et al (2011) Breast cancer statistics, 2011. CA Cancer J Clin 61(6):409–418
Homan SG, Kayani N, Yun S (2016) Risk factors, preventive practices, and health care among breast cancer survivors, United States, 2010. Prev Chronic Dis 13:E09
Runowicz CD, Leach CR, Henry NL et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34(6):611–635
Lam DL, Houssami N, Lee JM (2017) Imaging surveillance after primary breast cancer treatment. AJR Am J Roentgenol 208(3):676–686
Gradishar WJ, Anderson BO, Balassanian R et al (2017) NCCN guidelines insights: breast cancer, version 1.2017. J Natl Compr Cancer Netw 15(4):433–451
Schneble EJ, Graham LJ, Shupe MP et al (2014) Current approaches and challenges in early detection of breast cancer recurrence. J Cancer 5(4):281–290
Lash TL, Fox MP, Silliman RA (2006) Reduced mortality rate associated with annual mammograms after breast cancer therapy. Breast J 12(1):2–6
Lash TL, Fox MP, Buist DS et al (2007) Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol 25(21):3001–3006
Buist DS, Bosco JL, Silliman RA et al (2013) Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer. Breast Cancer Res Treat 142(1):153–163
Schootman M, Jeffe DB, Lian M et al (2008) Surveillance mammography and the risk of death among elderly breast cancer patients. Breast Cancer Res Treat 111(3):489–496
Freedman RA, Keating NL, Pace LE, et al (2017) Use of surveillance mammography among older breast cancer survivors by Life expectancy. J Clin Oncol
Freedman RA, Keating NL, Partridge AH et al (2017) Surveillance mammography in older patients with breast cancer-can we ever stop?: a review. JAMA Oncol 3(3):402–409
VanderWalde N, Jagsi R, Dotan E et al (2016) NCCN guidelines insights: older adult oncology, version 2.2016. J Natl Compr Canc Netw 14(11):1357–1370
Newman LA (2017) Breast cancer disparities: socioeconomic factors versus biology. Ann Surg Oncol. https://doi.org/10.1245/s10434-017-5977-1
Noone AM, Cronin KA, Altekruse SF et al (2017) Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992–2013. Cancer Epidemiol Biomark Prev 26(4):632–641
Jatoi I, Miller AB (2003) Why is breast-cancer mortality declining? Lancet Oncol 4(4):251–254
Keating NL, Landrum MB, Guadagnoli E et al (2006) Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol 24(1):85–94
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619
Klabunde CN, Potosky AL, Legler JM et al (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267
Israel BA, Schulz AJ, Parker EA et al (1998) Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health 19:173–202
Shirazi M, Engelman KK, Mbah O et al (2015) Targeting and tailoring health communications in breast screening interventions. Prog Community Health Partnersh-Res Educ Action 9:83–89
Cardarelli K, Jackson R, Martin M et al (2011) Community-based participatory approach to reduce breast cancer disparities in South Dallas. Prog Community Health Partnersh-Res Educ Action 5(4):375–385
Adams ML (2007) The African American breast cancer outreach project: partnering with communities. Fam Community Health 30(1 Suppl):S85–S94
Massin-Short SB, Grullon MA, Judge CM et al (2010) A mobile mammography pilot project to increase screening among Latina women of low socioeconomic status. Public Health Rep 125(5):765–771
Brooks SE, Hembree TM, Shelton BJ et al (2013) Mobile mammography in underserved populations: analysis of outcomes of 3,923 women. J Community Health 38(5):900–906
Drake BF, Abadin SS, Lyons S et al (2015) Mammograms on-the-go-predictors of repeat visits to mobile mammography vans in St Louis, Missouri, USA: a case-control study. BMJ Open 5(3):e006960
Blackman DJ, Masi CM (2006) Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol 24(14):2170–2178
Gerend MA, Pai M (2008) Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer Epidemiol Biomark Prev 17(11):2913–2923
Bickell NA, Moss AD, Castaldi M et al (2016) Organizational factors affect safety-net hospitals’ breast cancer treatment rates. Health Serv Res. https://doi.org/10.1111/1475-6773.12605
Peek ME, Han JH (2004) Disparities in screening mammography. Current status, interventions and implications. J Gen Intern Med 19(2):184–194
Charlot M, Santana MC, Chen CA et al (2015) Impact of patient and navigator race and language concordance on care after cancer screening abnormalities. Cancer 121(9):1477–1483
Braun KL, Kagawa-Singer M, Holden AE et al (2012) Cancer patient navigator tasks across the cancer care continuum. J Health Care Poor Underserved 23(1):398–413
Ferrante JM, Wu J, Dicicco-Bloom B (2011) Strategies used and challenges faced by a breast cancer patient navigator in an urban underserved community. J Natl Med Assoc 103(8):729–734
May DS, Kiefe CI, Funkhouser E et al (1999) Compliance with mammography guidelines: physician recommendation and patient adherence. Prev Med 28(4):386–394
Hawley ST, Earp JA, O’Malley M et al (2000) The role of physician recommendation in women’s mammography use: is it a 2-stage process? Med Care 38(4):392–403
Bickell NA, Weidmann J, Fei K et al (2009) Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. J Clin Oncol 27(31):5160–5167
Reyes SA, King TA, Fei K et al (2016) Factors affecting the completion of adjuvant chemotherapy in early-stage breast cancer. Ann Surg Oncol 23(5):1537–1542
Sarfati D, Koczwara B, Jackson C (2016) The impact of comorbidity on cancer and its treatment. CA Cancer J Clin 66(4):337–350
Ashing K, Rosales M, Lai L et al (2014) Occurrence of comorbidities among African-American and Latina breast cancer survivors. J Cancer Surviv 8(2):312–318
Land LH, Dalton SO, Jorgensen TL et al (2012) Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol Hematol 81(2):196–205
Field TS, Doubeni C, Fox MP et al (2008) Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med 23(2):158–163
Schapira MM, McAuliffe TL, Nattinger AB (2000) Underutilization of mammography in older breast cancer survivors. Med Care 38(3):281–289
Carcaise-Edinboro P, Bradley CJ, Dahman B (2010) Surveillance mammography for medicaid/medicare breast cancer patients. J Cancer Surviv 4(1):59–66
Snyder CF, Frick KD, Kantsiper ME et al (2009) Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol 27(7):1054–1061
Funding
This research was supported by a National Cancer Institute Cancer Prevention and Control Career Development Award (1K07CA166462 to JJL).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Wisnivesky is a member of the research board of EHE International, has received consulting honorarium from Merck Pharmaceuticals and IMS Health, and a research grant from Aventis. All other authors are without any conflicts of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
This study used de-identified data from the Surveillance, Epidemiology and End Results registry linked to Medicare claims (SEER-Medicare) and did not require informed consent to be obtained from this database.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Teysir, J., Gegechkori, N., Wisnivesky, J.P. et al. Racial disparities in surveillance mammography among older breast cancer survivors. Breast Cancer Res Treat 176, 461–467 (2019). https://doi.org/10.1007/s10549-019-05250-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-019-05250-8